胎儿囊性淋巴发育不良:关于怀孕和新生儿结局的系统审查
Diane Nzelu1, Ismini Panayotidis2, Gill D Smith3
1Women's Health, University College London Hospitals NHS Foundation Trust, London, UK.
概括
胎儿囊性淋巴发育不良 (LMs) 通常在出生前生长,但很少引起并发症. 这些非后部LMs的大部分幸存者取得了良好的发育结果.
科学领域:
- 周围生理学 周围生理学
- 胎儿医学 胎儿医学
- 医疗成像医学成像
背景情况:
- 胎儿囊性淋巴发育不良 (LMs) 需要仔细评估,以获得准确的患者咨询.
- 除了后LMs,了解相关的风险和结果至关重要.
结论:
- 胎儿囊性LMS (非后部) 很少与染色体或结构异常有关.
- 产前生长很常见,但严重的并发症很少见.
- 幸存者表现出有利的长期发展结果.
更多相关视频
相关概念视频
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Cystic Fibrosis: Pathogenesis
196
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
196


